Dipòsit Digital de Documents de la UAB 6 registres trobats  La cerca s'ha fet en 0.02 segons. 
1.
17 p, 3.1 MB Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci / Li, Tianlu (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ortiz-Fernández, L. (Instituto de Parasitología y Biomedicina "López-Neyra") ; Andrés-León, E. (Instituto de Parasitología y Biomedicina "López-Neyra") ; Ciudad, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Javierre, BM (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; López-Isac, E. (Instituto de Parasitología y Biomedicina "López-Neyra") ; Guillén-Del-Castillo, A. (Hospital Universitari Vall d'Hebron) ; Simeón-Aznar, C.P. (Hospital Universitari Vall d'Hebron) ; Ballestar, Esteban (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martin, J. (Instituto de Parasitología y Biomedicina "López-Neyra") ; Universitat Autònoma de Barcelona
Background: Systemic sclerosis (SSc) is a genetically complex autoimmune disease mediated by the interplay between genetic and epigenetic factors in a multitude of immune cells, with CD4+ T lymphocytes as one of the principle drivers of pathogenesis. [...]
2020 - 10.1186/s13073-020-00779-6
Genome Medicine, Vol. 12 Núm. 1 (25 2020) , p. 81  
2.
18 p, 6.6 MB A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer / López de Maturana, Evangelina (Centro de Investigación Biomédica en Red de Cáncer) ; Rodríguez, Juan Antonio (Barcelona Institute of Science and Technology (BIST). CNAG-CRG, Centre for Genomic Regulation (CRG)) ; Alonso, Lola (Centro de Investigación Biomédica en Red de Cáncer) ; Lao, Oscar (Barcelona Institute of Science and Technology (BIST). CNAG-CRG, Centre for Genomic Regulation (CRG)) ; Molina-Montes, Esther (Centro de Investigación Biomédica en Red de Cáncer) ; Martín-Antoniano, Isabel Adoración (Centro de Investigación Biomédica en Red de Cáncer) ; Gómez-Rubio, Paulina (Centro de Investigación Biomédica en Red de Cáncer) ; Lawlor, Rita (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics) ; Carrato, Alfredo (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Hidalgo, Manuel (Weill Cornell Medicine) ; Iglesias, Mar (Parc de Salut Mar (Barcelona, Catalunya)) ; Molero, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Löhr, Matthias (Gastrocentrum, Karolinska Institutet and University Hospital) ; Michalski, Christopher (Martin-Luther-University Halle-WittenberHalle (Saale). Department of Visceral, Vascular and Endocrine Surgery) ; Perea, José (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; O'Rorke, Michael (The University of Iowa. College of Public Health) ; Barberà, Victor Manuel (Molecular Genetics Laboratory, General University Hospital of Elche, Elche, Spain) ; Tardón, Adonina (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Farré, Antoni (Institut d'Investigació Biomèdica Sant Pau) ; Muñoz-Bellvís, Luís (Universidad de Salamanca. Department of Surgery, Hospital Universitario de Salamanca - IBSAL) ; Crnogorac-Jurcevic, Tanja (Queen Mary University of London. Barts Cancer Institute, Centre for Molecular Oncology) ; Domínguez-Muñoz, Enrique (University Clinical Hospital of Santiago de Compostela. Department of Gastroenterology) ; Gress, Thomas (University Hospital of Giessen and Marburg. Department of Gastroenterology) ; Greenhalf, William (University of Liverpool. Department of Molecular and Clinical Cancer Medicine) ; Sharp, Linda (Newcastle University, Institute of Health & Society) ; Arnes, Luís (Columbia University Medical Center. Department of Systems Biology) ; Cecchini, Lluís (Parc de Salut Mar (Barcelona, Catalunya)) ; Balsells, Joaquim (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Costello, Eithne (University of Liverpool. Department of Molecular and Clinical Cancer Medicine) ; Ilzarbe, Lucas (Parc de Salut Mar (Barcelona, Catalunya)) ; Kleeff, Jörg (Martin-Luther-University Halle-WittenberHalle (Saale). Department of Visceral, Vascular and Endocrine Surgery) ; Kong, Bo (Technical University of Munich. Department of Surgery) ; Márquez, Mirari (Centro de Investigación Biomédica en Red de Cáncer) ; Mora Brugués, Josefina (Institut d'Investigació Biomèdica Sant Pau) ; O'Driscoll, Damian (University College Cork. National Cancer Registry Ireland and HRB Clinical Research Facility) ; Scarpa, Aldo (University and Hospital Trust of Verona. ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics) ; Ye, Weimin (Karolinska Institutet. Department of Medical Epidemiology and Biostatistics) ; Yu, Jingru (Karolinska Institutet. Department of Medical Epidemiology and Biostatistics) ; García-Closas, Montserrat (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Kogevinas, M. (Hospital del Mar (Barcelona, Catalunya)) ; Rothman, Nathaniel (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Silverman, Debra T (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Albanes, Demetrius (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Arslan, Alan A (New York University School of Medicine. Department of Population Health) ; Beane-Freeman, Laura (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Bracci, Paige M (University of California. Department of Epidemiology and Biostatistics) ; Brennan, Paul (International Agency for Research on Cancer (IARC)) ; Bueno-de-Mesquita, Bas (National Institute for Public Health and the Environment (RIVM). Deparment for Determinants of Chronic Diseases (DCD)) ; Buring, Julie (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Canzian, Federico (German Cancer Research Center (DKFZ. Genomic Epidemiology Group) ; Du, Margaret (Memorial Sloan Kettering Cancer Center) ; Gallinger, Steve (Sinai Health System. Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute) ; Gaziano, J Michael (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Goodman, Phyllis J (SWOG Statistical Center, Fred Hutchinson Cancer Research Center) ; Gunter, Marc (International Agency for Research on Cancer (IARC)) ; LeMarchand, Loic (University of Hawaii Cancer Center. Cancer Epidemiology Program) ; Li, Donghui (University of Texas MD Anderson Cancer Center) ; Neale, Rachael E (QIMR Berghofer Medical Research Institute. Population Health Department) ; Peters, Ulrika (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences) ; Petersen, Gloria M (Mayo Clinic College of Medicine. Department of Health Sciences Research) ; Risch, Harvey A (Yale School of Public Health. Department of Chronic Disease Epidemiology) ; Sánchez, Maria José (Universidad de Granada) ; Shu, Xiao-Ou (Vanderbilt University School of Medicine. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center) ; Thornquist, Mark D (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences) ; Visvanathan, Kala (Mayo Clinic College of Medicine. Department of Health Sciences Research) ; Zheng, Wei (Vanderbilt University School of Medicine. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center) ; Chanock, Stephen J (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Easton, Douglas (University of Cambridge. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care) ; Wolpin, Brian M (Dana-Farber Cancer Institute. Department Medical Oncology) ; Stolzenberg-Solomon, Rachael Z (National Institutes of Health. Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Klein, Alison P (Johns Hopkins School of Medicine. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center) ; Amundadottir, Laufey T (National Institutes of Health. Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute) ; Marti-Renom, Marc A (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Real, Francisco X (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Malats, Núria (Centro de Investigación Biomédica en Red de Cáncer)
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4. [...]
2021 - 10.1186/s13073-020-00816-4
Genome Medicine, Vol. 13 (february 2021)  
3.
23 p, 4.1 MB Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns / Mateo, Lidia (Institute for Research in Biomedicine (IRB Barcelona)) ; Duran-Frigola, Miquel (Institute for Research in Biomedicine (IRB Barcelona)) ; Gris-Oliver, Albert (Vall d'Hebron Institut d'Oncologia) ; Palafox, Marta (Vall d'Hebron Institut d'Oncologia) ; Scaltriti, Maurizio (MSKCC. Department of Pathology) ; Razavi, Pedram (MSKCC and Weill-Cornell Medical College. Breast Medicine Service, Department of Medicine) ; Chandarlapaty, Sarat (MSKCC and Weill-Cornell Medical College. Breast Medicine Service, Department of Medicine) ; Arribas, Joaquin (Vall d'Hebron Institut d'Oncologia) ; Bellet, Meritxell (Vall d'Hebron Institut d'Oncologia) ; Serra, Violeta (Vall d'Hebron Institut d'Oncologia) ; Aloy, Patrick (Institució Catalana de Recerca i Estudis Avançats (ICREA))
Identification of actionable genomic vulnerabilities is key to precision oncology. Utilizing a large-scale drug screening in patient-derived xenografts, we uncover driver gene alteration connections, derive driver co-occurrence (DCO) networks, and relate these to drug sensitivity. [...]
2020 - 10.1186/s13073-020-00774-x
Genome Medicine, Vol. 12 (september 2020)  
4.
18 p, 4.3 MB Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis / Lorente-Sorolla, C. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Garcia-Gomez, Antonio (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Català-Moll, Francesc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Toledano, Víctor (La Paz University Hospital. Emergency Department, IdiPAZ) ; Ciudad, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Avendaño-Ortiz, José (La Paz University Hospital. Emergency Department, IdiPAZ) ; Maroun-Eid, Charbel (Instituto de Investigación Hospital Universitario La Paz) ; Martín-Quirós, Alejandro (La Paz University Hospital. Emergency Department, IdiPAZ) ; Martínez-Gallo, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Sanmartín, Adolfo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; del Campo, Álvaro García (Hospital Universitari Vall d'Hebron) ; Ferrer, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Rodriguez, Juan Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Álvarez-Errico, Damiana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ballestar, Esteban (Institut d'Investigació Biomèdica de Bellvitge) ; VHIR Vall d'Hebron Institut de Recerca ; Universitat Autònoma de Barcelona
Sepsis, a life-threatening organ dysfunction caused by a dysregulated systemic immune response to infection, associates with reduced responsiveness to subsequent infections. How such tolerance is acquired is not well understood but is known to involve epigenetic and transcriptional dysregulation. [...]
2019 - 10.1186/s13073-019-0674-2
Genome Medicine, Vol. 11 (october 2019)  
5.
8 p, 2.4 MB Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations / Tamborero, David (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rubio-Perez, Carlota (Institut Hospital del Mar d'Investigacions Mèdiques) ; Deu-Pons, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Schroeder, Michael P. (Charité-Universitätsmedizin (Germany)) ; Vivancos, Ana (Vall d'Hebron Institut d'Oncologia) ; Rovira, Ana (Institut Hospital del Mar d'Investigacions Mèdiques) ; Tusquets, Ignasi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Albanell, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rodón Ahnert, Jordi (Vall d'Hebron Institut d'Oncologia) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; de Torres, Carmen (Institut de Recerca Sant Joan de Déu) ; Dienstmann, Rodrigo (Vall d'Hebron Institut d'Oncologia) ; Gonzalez-Perez, Abel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Lopez-Bigas, Nuria (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Universitat Autònoma de Barcelona
While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Here we present the Cancer Genome Interpreter, a versatile platform that automates the interpretation of newly sequenced cancer genomes, annotating the potential of alterations detected in tumors to act as drivers and their possible effect on treatment response. [...]
2018 - 10.1186/s13073-018-0531-8
Genome Medicine, Vol. 10 (March 2018) , art. 25  
6.
12 p, 2.5 MB Cancer network activity associated with therapeutic response and synergism / Serra-Musach, Jordi (Institut Català d'Oncologia) ; Mateo, Francesca (Institut Català d'Oncologia) ; Capdevila-Busquets, Eva (Institut de Recerca Biomèdica de Lleida) ; de Garibay, Gorka Ruiz (Institut Català d'Oncologia) ; Zhang, Xiaohu (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Guha, Raj (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Thomas, Craig J. (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Grueso, Judit (Vall d'Hebron Institut d'Oncologia) ; Villanueva, Alberto (Institut Català d'Oncologia) ; Jaeger, Samira (Institut de Recerca Biomèdica de Lleida) ; Heyn, Holger (Institut d'Investigació Biomèdica de Bellvitge) ; Vizoso, Miguel (Institut d'Investigació Biomèdica de Bellvitge) ; Pérez, Hector (Institut d'Investigació Biomèdica de Bellvitge) ; Cordero, Alex (Institut d'Investigació Biomèdica de Bellvitge) ; Gonzalez-Suarez, Eva (Institut d'Investigació Biomèdica de Bellvitge) ; Esteller, Manel (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Moreno-Bueno, Gema (Universidad Autónoma de Madrid. Departamento de Bioquímica) ; Tjärnberg, Andreas (Linköping University. Departament of Clinical and Experimental Medicine) ; Lázaro, Conxi (Institut Català d'Oncologia) ; Serra, Violeta (Vall d'Hebron Institut d'Oncologia) ; Arribas, Joaquín V. (Vicente) (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Benson, Mikael (Linköping University. Department of Clinical and Experimental Medicine) ; Gustafsson, Mika (Linköping University. Department of Clinical and Experimental Medicine) ; Ferrer, Marc (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Aloy, Patrick (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Pujana, Miquel Àngel (Institut Català d'Oncologia)
Cancer patients often show no or only modest benefit from a given therapy. This major problem in oncology is generally attributed to the lack of specific predictive biomarkers, yet a global measure of cancer cell activity may support a comprehensive mechanistic understanding of therapy efficacy. [...]
2016 - 10.1186/s13073-016-0340-x
Genome Medicine, Vol. 8 (August 2016) , ART. 88  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.